Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (FRA:FDY)

FRA:FDY Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 19, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	867	821	933	932	1,515	1,659
Market Cap Growth	10.81%	-12.02%	0.10%	-38.47%	-8.66%	252.18%
Enterprise Value	736	680	793	771	1,365	1,502
PE Ratio	-	156.13	67.32	49.79	51.31	80.44
PS Ratio	10.18	8.74	8.60	6.66	9.60	15.89
PB Ratio	3.21	2.69	3.10	3.05	5.00	6.60
P/TBV Ratio	3.30	2.78	3.22	3.13	5.20	6.78
P/FCF Ratio	72.94	-	-	88.13	73.56	187.64
P/OCF Ratio	48.40	-	102.98	41.57	40.70	117.22
EV/Sales Ratio	8.72	7.24	7.31	5.51	8.65	14.39
EV/EBITDA Ratio	-	112.28	48.18	30.41	45.55	62.59
EV/EBIT Ratio	-	-	80.59	49.83	60.61	84.03
EV/FCF Ratio	61.93	-	-	72.92	66.29	169.90
Debt / Equity Ratio	0.01	0.01	0.01	0.06	0.01	0.01
Debt / EBITDA Ratio	-	0.38	0.13	0.64	0.14	0.10
Debt / FCF Ratio	0.16	-	-	1.60	0.21	0.28
Net Debt / Equity Ratio	-0.49	-0.45	-0.50	-0.53	-0.54	-0.69
Net Debt / EBITDA Ratio	21.89	-22.64	-9.13	-6.39	-5.44	-7.19
Net Debt / FCF Ratio	-11.10	17.50	42.17	-15.32	-7.91	-19.51
Asset Turnover	0.28	0.26	0.29	0.36	0.43	0.41
Inventory Turnover	1.88	1.40	1.76	2.27	2.26	1.95
Quick Ratio	8.40	6.08	3.60	2.98	3.56	4.63
Current Ratio	8.68	6.40	3.70	3.07	3.65	4.74
Return on Equity (ROE)	-2.73%	1.69%	4.70%	6.18%	10.12%	11.17%
Return on Assets (ROA)	-2.58%	-0.18%	1.65%	2.48%	3.85%	4.39%
Return on Invested Capital (ROIC)	-8.95%	-0.63%	6.89%	11.02%	19.48%	23.22%
Return on Capital Employed (ROCE)	-4.60%	-0.30%	3.30%	5.00%	7.20%	6.90%
Earnings Yield	-0.87%	0.64%	1.49%	2.01%	1.95%	1.24%
FCF Yield	1.37%	-0.95%	-0.38%	1.14%	1.36%	0.53%
Payout Ratio	-	234.79%	70.10%	51.48%	24.45%	42.37%
Buyback Yield / Dilution	24.84%	-0.23%	-0.29%	1.29%	-5.59%	-7.20%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.